community-acquired pneumonia — MRCGP AKT MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: B — Oral amoxicillin 500 mg three times daily for 5 days
The correct answer is B. This patient has a CRB65 score of 0 and no clinical feature that increases the assessed severity, so this is low-severity community-acquired pneumonia suitable for primary care treatment. NICE recommends oral amoxicillin 500 mg three times daily for 5 days as first-line therapy. Clarithromycin is an alternative when there is penicillin allergy or amoxicillin is unsuitable, for example when an atypical pathogen is suspected. Co-amoxiclav plus a macrolide is used for high-severity disease, while levofloxacin is an alternative in high-severity disease with penicillin allergy and carries important fluoroquinolone safety restrictions. An intravenous ceftriaxone-based regimen is not indicated for uncomplicated low-severity disease managed in the community.
Reference: National Institute for Health and Care Excellence. NG250, Pneumonia: diagnosis and management, section 1.6 and Table 1: antibiotics for treating community-acquired pneumonia in adults. Published 2025; amended January 2026. https://www.nice.org.uk/guidance/ng250/chapter/recommendations